Joint analysis of the metabolomics and transcriptomics uncovers the dysregulated network and develops the diagnostic model of high-risk neuroblastoma

Abstract High-risk neuroblastoma (HR-NB) has a significantly lower survival rate compared to low- and intermediate-risk NB (LIR-NB) due to the lack of risk classification diagnostic models and effective therapeutic targets. The present study aims to characterize the differences between neuroblastoma...

ver descrição completa

Detalhes bibliográficos
Main Authors: Bang Du, Fei Zhang, Qiumei Zhou, Weyland Cheng, Zhidan Yu, Lifeng Li, Jianwei Yang, Xianwei Zhang, Chongchen Zhou, Wancun Zhang
Formato: Artigo
Idioma:English
Publicado em: Nature Portfolio 2023-10-01
Colecção:Scientific Reports
Acesso em linha:https://doi.org/10.1038/s41598-023-43988-w